Vol 19, No 1 (2012)



Table of Contents

Guest Editorials

EGFR tyrosine kinase inhibitors in lung cancer: make no assumptions PDF HTML
B. Melosky 8
A model for breast cancer risk based on stem-cell theory PDF HTML
S. A. Narod 9-11
Cancer control: life and death in an unequal world PDF HTML
S. B. Sutcliffe 12-15
A call for action in survivorship research and care PDF HTML
R. Doll, A. Kazanjian, K. Smillie, A. Ward, M. Chasen 16-20

Letter to the Editor

Second-line erlotinib in an EGFR mutation-negative patient with non-small-cell lung cancer PDF HTML
V. Hirsh 21-22

E-Manuscript Article Summaries

E-manuscript Article Summaries PDF HTML
  23-26

Cancer Biomarkers

Increased alpha-fetoprotein receptor in the serum of patients with early-stage breast cancer PDF HTML
R. Moro, J. Gulyaeva–Tcherkassova, P. Stieber e1-8

Knowledge Translation

Challenges in knowledge translation: the early years of Cancer Care Ontario’s Program in Evidence-Based Care PDF HTML
G. P. Browman 27-35

Medical Oncology

Role of pemetrexed in advanced non-small-cell lung cancer: meta-analysis of randomized controlled trials, with histology subgroup analysis PDF HTML
K. Alsaleh, C. Quinton, P. M. Ellis e9-15

Oncologic Pathology

Fine-needle aspiration biopsy versus core-needle biopsy in diagnosing lung cancer: a systematic review PDF HTML
X. Yao, M. M. Gomes, M. S. Tsao, C. J. Allen, W. Geddie, H. Sekhon e16-27

Updates and Developments in Oncology

Understanding and overcoming chemoresistance in ovarian cancer: emerging role of the endothelin axis PDF HTML
A. Bagnato, L. Rosanò 36-38
Major histocompatibility complex class i and tumour immuno-evasion: how to fool T cells and natural killer cells at one time PDF HTML
D. Fruci, M. Benevolo, L. Cifaldi, S. Lorenzi, E. Lo Monaco, E. Tremante, P. Giacomini 39-41
Phase i study of the Plk1 inhibitor BI 2536 administered intravenously on three consecutive days in advanced solid tumours PDF HTML
A. Frost, K. Mross, S. Steinbild, S. Hedbom, C. Unger, R. Kaiser, D. Trommeshauser, G. Munzert e28-35

Case Report

Response to second-line erlotinib in an EGFR mutation-negative patient with non-small-cell lung cancer: make no assumptions PDF HTML
I. Karam, B. Melosky 42-46
Medullary thyroid cancer and pseudocirrhosis: case report and literature review PDF HTML
B. L. Harry, M.L. Smith, J.R. Burton Jr, A. Dasari, S.G. Eckhardt, J.R. Diamond e36-41

Corrigenda

Corrigendum: Survival and treatment patterns in elderly patients with advanced non-small-cell lung cancer in Manitoba PDF HTML
  e42





Copyright © 2012 Multimed Inc.
ISSN: 1198-0052 (Print) ISSN: 1718-7729 (Online)